| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 11430 |
| 1 | MEPOLIZUMAB | 1428 |
| 2 | BELIMUMAB | 938 |
| 3 | SOMATROPIN | 742 |
| 4 | INSULIN GLARGINE | 741 |
| 5 | ALBUTEROL SULFATE | 447 |
| 6 | PREDNISONE | 255 |
| 7 | ERGOCALCIFEROL | 246 |
| 8 | OMALIZUMAB | 227 |
| 9 | TOCILIZUMAB | 206 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | USTEKINUMAB-AAUZ | 2 | 0.2000 |
| 1 | ARNICA MONTANA FLOWER | 7 | 0.0843 |
| 2 | WHITE PETROLATUM MINERAL OIL | 2 | 0.0690 |
| 3 | PERFLUOROHEXYLOCTANE | 101 | 0.0621 |
| 4 | INSULIN GLARGINE AND LIXISENATIDE | 172 | 0.0502 |
| 5 | CLINDAMYCIN PHOSPHATE/BENZOYL PEROXIDE/ADAPALENE | 2 | 0.0435 |
| 6 | BELIMUMAB | 938 | 0.0304 |
| 7 | MEPOLIZUMAB | 1428 | 0.0296 |
| 8 | USTEKINUMAB-STBA | 8 | 0.0290 |
| 9 | DUPILUMAB | 11430 | 0.0261 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 11430 |
| 1 | Interleukin-5 Antagonist [EPC] | 1429 |
| 2 | Insulin Analog [EPC] | 972 |
| 3 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 938 |
| 4 | Corticosteroid [EPC] | 576 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 425 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 391 |
| 7 | GLP-1 Receptor Agonist [EPC] | 334 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 278 |
| 9 | Provitamin D2 Compound [EPC] | 246 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Semifluorinated Alkane [EPC] | 101 | 0.0621 |
| 1 | Antithrombin-directed RNA Interaction [EPC] | 1 | 0.0345 |
| 2 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 938 | 0.0304 |
| 3 | Interleukin-5 Antagonist [EPC] | 1429 | 0.0292 |
| 4 | Interleukin-4 Receptor alpha Antagonist [EPC] | 11430 | 0.0261 |
| 5 | Small Interfering RNA [EPC] | 1 | 0.0222 |
| 6 | Oxaborole Antifungal [EPC] | 1 | 0.0182 |
| 7 | Ectoparasiticide [EPC] | 40 | 0.0160 |
| 8 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 14 | 0.0080 |
| 9 | Interferon alfa-2b [EPC] | 12 | 0.0072 |